Abraham Boskovitz Selected Research

1,3,4,6-tetrachloro-3 alpha,6 alpha-diphenylglycoluril

1/2012	Radioimmunotargeting of malignant glioma by monoclonal antibody D2C7 reactive against both wild-type and variant III mutant epidermal growth factor receptors.
4/2004	Human/murine chimeric 81C6 F(ab')(2) fragment: preclinical evaluation of a potential construct for the targeted radiotherapy of malignant glioma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Abraham Boskovitz Research Topics

Disease

8	Neoplasms (Cancer) 11/2015 - 04/2004
2	Glioma (Gliomas) 01/2012 - 04/2004
1	Glioblastoma (Glioblastoma Multiforme) 12/2011
1	Meningeal Carcinomatosis 08/2009
1	Breast Neoplasms (Breast Cancer) 08/2009
1	Medulloblastoma 12/2004
1	Meningitis 12/2004
1	Brain Neoplasms (Brain Tumor) 04/2004

Drug/Important Bio-Agent (IBA)

4	Monoclonal AntibodiesIBA 01/2012 - 04/2004
3	ErbB Receptors (EGF Receptor)IBA 01/2012 - 02/2009
2	1,3,4,6-tetrachloro-3 alpha,6 alpha-diphenylglycolurilIBA 01/2012 - 04/2004
1	Epidermal Growth Factor (EGF)IBA 01/2012
1	epidermal growth factor receptor VIIIIBA 01/2012
1	LigandsIBA 12/2011
1	Trastuzumab (Herceptin)FDA Link 08/2009
1	Therapeutic UsesIBA 08/2009
1	Peptides (Polypeptides)IBA 12/2004
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 12/2004
1	Octreotide (Sandostatin)FDA LinkGeneric 12/2004
1	Somatostatin Receptors (Somatostatin Receptor)IBA 12/2004
1	AntigensIBA 09/2004
1	TenascinIBA 04/2004

Therapy/Procedure

4	Therapeutics 01/2012 - 12/2004
1	Endoscopes 11/2015
1	Catheters 08/2009
1	Immunotherapy 09/2004
1	Radiotherapy 04/2004